Being restricted to marketing and sales, the division had no influence over corporate financial and production activities. It lacked local talent to train customers and collect data on the efficacy of new products. Most importantly, because it was perceived as a low-price brand in Asia, it didn’t have a network of local healthcare professionals to help validate and market its products.
There had been limited appetite for creating an integrated Asian network of healthcare professionals. The market was fragmented, with widely varying levels of insurance and service, and the division’s financing was tight. The go-to approach for Wei Ling’s division was to deploy light touch training for customers and let the market validate the efficacy of a new product through use.
However, Wei Ling realized that, in contrast to differences in regional regulations, healthcare professionals across markets shared similar professional interests and practical concerns when applying new treatments. This meant that an Asian network of healthcare professionals could be envisaged.
Applying the SVCC, Wei Ling saw that an Asian network would enhance asset creation at three points in the value-creating cycle: as value-creating partners participating in the validation of the value proposition, as societal partners enhancing the brand’s value by participating in an online dialogue about healthcare, and as customers creating demand for the company’s products. The division’s most value-critical stakeholder was a missing network of Asian healthcare professionals.
A solution to the dispute between the research and marketing departments was in Wei Ling’s hands. Apart from corporate finance’s refusal to provide resources for additional stakeholder activities, the critical constraint on the SVCC was the division’s recruiting process. The potential value-creating leverage would be considerable if this constraint were loosened. The SVCC diagram made it easier for Wei Ling to highlight the importance of missing stakeholder support and to quickly persuade her regional CEO to see that the recruiting process for talent and Asian healthcare partners was the most immediately available leverage point for value creation. Once the CEO realized the potential payoff from bringing in these stakeholders, he agreed to take the risk of reallocating some of the division’s limited resources for investment in new talent despite profit pressure.
Mobilize value-critical stakeholders
To optimize the ecosystem represented by the SVCC, you must do three things:
1. Integrate effectively
The relevant stakeholders must be explicitly integrated into the creation of soft assets. To help enhance her brand’s image in Asia, Wei Ling – after talking to Marketing – realized it was critical to take account of differing regulatory regimes by collecting and analyzing clinical data from different sources. This would validate the efficacy of new value propositions in the Asian context. To access field data, Wei Ling’s team developed an Asian network of healthcare professionals and others involved in using the new treatment.
The organization created two internal stakeholder teams to interface with the external network: an internal digital team to collect and process data and a mixed internal and external education team to help customers use the treatment.
To further enhance the brand’s image, Wei Ling followed the company’s practice in its home market. She encouraged the digital team to extend its reach beyond healthcare professionals and to incorporate patients in dialogue about their needs.
2. Share value
The value created must be shared to ensure ongoing stakeholder commitment to developing and maintaining assets. Quality assets require the long-term commitment of those stakeholders relevant to value creation. Soft assets, in particular, take time to develop and are very vulnerable to neglect.
In addition to access and training in the use of the new treatment, healthcare professionals received online access to the company’s international selection of scientific resources, as well as updates and best practices from the field and conferences on the latest innovations. Patients were invited to ongoing experience-sharing events to help them understand how to make the best decisions for their health.
Drawing on the company’s extensive employee development program, Wei Ling was able to offer the new digital and educational teams an attractive value proposition involving exposure and integration into the corporate digital network, further digital and AI education, and related opportunities for promotion based on their contribution to clinical trials and their record in helping customers adopt the new treatment.
3. Keep score
Given the importance of quantitative financial data for investors and financial markets, a special effort is needed to monitor the quality of soft assets and any related stakeholder engagement. A stakeholder ecosystem can play a major role in keeping engagement in the creation of soft assets “front of mind”. In the healthcare industry, a well-tended ecosystem of employee, technology, and industry partners, as well as active healthcare professionals and patients, plays a big part in sustaining value propositions, image, and brand, as well as the capabilities on which they depend, at the top of the executive agenda.
To avoid blind spots, boards, and senior teams need communication channels and people in their ranks who are receptive to what’s happening on the frontline. In the case of the global healthcare company, this meant top executives at headquarters who were sensitive to the right degree of risk-taking in R&D and communication with the Asian market. In Wei Ling’s division, the capabilities to support communication with headquarters were absent until she recruited healthcare experts who emphasized the value of local clinical data and training.
The ultimate test of the value created by stakeholders is the long-term financial performance of the value-creating cycle. Once the clinical data was in, Wei Ling’s division ramped up its marketing of the new treatment. The company’s image locally benefited, revenues increased, and the return on investment began to approach the corporate target. Wei Ling demonstrated the value that can be created by identifying critical stakeholders, integrating them effectively, sharing value, and keeping score.